Zweig DiMenna Associates LLC Acquires Shares of 295,357 agilon health, inc. (NYSE:AGL)

Zweig DiMenna Associates LLC acquired a new position in agilon health, inc. (NYSE:AGL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 295,357 shares of the company's stock, valued at approximately $3,707,000. Zweig DiMenna Associates LLC owned approximately 0.07% of agilon health at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Morgan Stanley grew its holdings in agilon health by 8.9% in the 3rd quarter. Morgan Stanley now owns 44,819,378 shares of the company's stock worth $795,992,000 after buying an additional 3,674,311 shares in the last quarter. Wellington Management Group LLP grew its holdings in agilon health by 8.3% in the 3rd quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company's stock worth $733,821,000 after buying an additional 3,162,094 shares in the last quarter. Vanguard Group Inc. grew its holdings in agilon health by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 28,355,275 shares of the company's stock worth $503,590,000 after buying an additional 111,487 shares in the last quarter. BlackRock Inc. grew its holdings in agilon health by 48.1% in the 2nd quarter. BlackRock Inc. now owns 12,916,511 shares of the company's stock worth $223,972,000 after buying an additional 4,194,593 shares in the last quarter. Finally, Capital Research Global Investors grew its holdings in agilon health by 18.4% in the 1st quarter. Capital Research Global Investors now owns 9,867,875 shares of the company's stock worth $250,151,000 after buying an additional 1,536,506 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts have issued reports on AGL shares. SVB Leerink lowered agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, January 8th. JPMorgan Chase & Co. lowered agilon health from an "overweight" rating to a "neutral" rating and decreased their price target for the company from $17.00 to $9.00 in a research note on Friday, January 5th. Evercore ISI decreased their price target on agilon health from $7.00 to $6.00 and set an "in-line" rating for the company in a research note on Wednesday, February 28th. Royal Bank of Canada decreased their price target on agilon health from $11.00 to $8.00 and set an "outperform" rating for the company in a research note on Wednesday, February 28th. Finally, Jefferies Financial Group reaffirmed a "hold" rating and set a $6.50 price target (down from $25.00) on shares of agilon health in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $9.73.

agilon health Stock Down 1.9 %

Shares of AGL traded down $0.09 during mid-day trading on Friday, reaching $4.75. The company's stock had a trading volume of 2,713,416 shares, compared to its average volume of 4,757,952. The business has a fifty day moving average of $5.97 and a 200 day moving average of $10.77. The company has a market cap of $1.95 billion, a price-to-earnings ratio of -7.31 and a beta of 0.49. agilon health, inc. has a 1 year low of $4.44 and a 1 year high of $28.99. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05.

agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.13). The business had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. agilon health's revenue for the quarter was up 71.8% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.14) EPS. As a group, analysts forecast that agilon health, inc. will post -0.35 earnings per share for the current fiscal year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.